| Entry |
|
| Name |
Interferon alfacon-1 (USAN/INN); Interferon alfacon-1 (genetical recombination) (JAN); Advaferon (TN); Infergen (TN) |
| Abbr |
CIFN |
| Formula |
C870H1366N236O259S9
|
| Exact mass |
19551.846
|
| Mol weight |
19564.1658
|
| Class |
Immunological agent
DG01752 Interferone
|
| Remark |
| ATC code: | L03AB09 S01AD05 |
|
| Efficacy |
Antiviral, Biological response modifier |
| Target |
IFNAR1 [HSA:3454] [KO:K05130] IFNAR2 [HSA:3455] [KO:K05131] |
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04630 | JAK-STAT signaling pathway |
| hsa04650 | Natural killer cell mediated cytotoxicity |
|
| Interaction |
|
| Structure map |
| map07044 | Antiviral agents |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB09 Interferon alfacon-1
D02744 Interferon alfacon-1 (USAN/INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD05 Interferon
D02744 Interferon alfacon-1 (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
D02744 Interferon alfacon-1
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D02744 Interferon alfacon-1 (USAN/INN)
IFNAR2
D02744 Interferon alfacon-1 (USAN/INN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D02744 Interferon alfacon-1 (USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D02744 Interferon alfacon-1 (USAN/INN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02744
|
| Other DBs |
|